Plus Therapeutics Files 8-K Report
Ticker: PSTV · Form: 8-K · Filed: Aug 14, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $2.5 million, $3 million, $2 million, $50.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-history
TL;DR
PLUS THERAPEUTICS filed an 8-K on 8/14/25 covering other events and financials.
AI Summary
On August 14, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The company, formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC, is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This 8-K filing provides updates on significant company events and financial disclosures, which are crucial for investors to understand the current status and potential future direction of Plus Therapeutics.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report detailing events and financial statements, not indicating any immediate or significant adverse developments.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- August 14, 2025 (date) — Date of earliest event reported
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Houston, Texas (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Plus Therapeutics?
The primary purpose of this 8-K filing is to report on "Other Events" and "Financial Statements and Exhibits" as of August 14, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 14, 2025.
What were Plus Therapeutics' former company names?
Plus Therapeutics, Inc. was formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC.
In which state is Plus Therapeutics, Inc. incorporated?
Plus Therapeutics, Inc. is incorporated in Delaware.
What is the address of Plus Therapeutics' principal executive offices?
The address of Plus Therapeutics' principal executive offices is 2710 Reed Road, Suite 160, Houston, Texas 77051.
Filing Stats: 817 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2025-08-14 16:27:43
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 PSTV The Nasdaq Capital Market Ind
- $2.5 million — ket ("Nasdaq") to maintain a minimum of $2.5 million in stockholders' equity (the "Equity Ru
- $3 million — ompany reported stockholders' equity of $3 million and therefore satisfied the Equity Rule
- $2 million — une 30, 2025, the Company has sold over $2 million in common stock pursuant to its newly e
- $50.0 million — stock pursuant to its newly established $50.0 million equity line of credit ("ELOC") with Lin
- $35 m — listed securities ("MVLS") of at least $35 million, which is an alternative threshol
Filing Documents
- d824499d8k.htm (8-K) — 25KB
- d824499dex991.htm (EX-99.1) — 30KB
- 0001193125-25-180814.txt ( ) — 170KB
- pstv-20250814.xsd (EX-101.SCH) — 3KB
- pstv-20250814_lab.xml (EX-101.LAB) — 18KB
- pstv-20250814_pre.xml (EX-101.PRE) — 11KB
- d824499d8k_htm.xml (XML) — 4KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 14, 2025 PLUS THERAPEUTICS, INC. By: /s/ Marc H. Hedrick, M.D. Marc H. Hedrick, M.D. President and Chief Executive Officer